Neutrophil Side Fluorescent Light (NEU-SFL) in COVID-19 Patients
Completed
- Conditions
- COVID-19
- Registration Number
- NCT05413824
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
Recently, a study showed that markers of neutrophil extracellular traps formation, a mechanism corresponding to neutrophil activation, were increased in patients who died of COVID 19 compared with survivors.
The investigators propose to analyze the NEU-SFL parameter, obtained automatically on the Sysmex™ blood count machine (Sysmex Corporation, Kobe, Japan) and which is considered as a reflect of neutrophil extracellular traps formation, in these two groups of patients. The aim was to evaluate whether this parameter could be used to predict the risk of death related to COVID 19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2233
Inclusion Criteria
- Hospitalization for COVID 19 in 2021
Exclusion Criteria
- Patients who refused the use of their data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the rate of NEU-SFL in patients hospitalized at Nimes hospital for COVID-19 in 2021, according they survived or not. 3 months Data collection
- Secondary Outcome Measures
Name Time Method Compare the rate of NEU-SFL in patients hospitalized at Nimes hospital for COVID-19 in 2021 who survived, between entry and discharge from Nimes hospital 3 months Data collection
Compare the rate of NEU-SFL in patients hospitalized at Nimes hospital for COVID-19 in 2021 who died, between entry and discharge from Nimes hospital 3 months Data collection
Trial Locations
- Locations (1)
CHU Nimes
🇫🇷Nîmes, France